Announcing CHI's Mastering Risk-Based Monitoring Conference, May 9-10, 2016, Boston

Proactively building quality standards and risk management into the design and planning of clinical trials.
 
NEEDHAM, Mass. - April 1, 2016 - PRLog -- Cambridge Healthtech Institute (CHI) released today the agenda for its seventh annual Mastering Risk-Based Monitoring conference to be held on May 9-10, 2016 at the Westin Boston Waterfront Hotel in Boston, MA, as part of the fifth annual Clinical Trial Innovation Summit.

Confirmed Presentations:

CASE STUDY: A Practical Guide to Successful RBM Implementation
Stacy Foley, Project Director, Global Risk-Based Monitoring Implementation, Merck

Co-Presentation: Novo Nordisk's Journey into RBM
Kate Owen, Vice President, Clinical Trial Management, Novo Nordisk
Heather Achenbach, Senior Director, Clinical Trial Management, Novo Nordisk

Lessons I Wish Someone Had Told Me: Risk-Based Monitoring Implementation Challenges
Sheryl Jacobs, Vice President, Global Study Operations, Amgen

A Next-Generation Platform for Clinical Data Integration and Risk-Based Monitoring: Why Data and User Centricity Matters
Dimitris Agrafiotis, Ph.D., Vice President, Chief Data Office & Head, Technology Products, Covance Inc.
Sponsored by: Covance Inc.

Presentation to be announced
Sponsored by: Medidata

Co-Presentation: A Case Study in Searching for a Technology Solution to Support Risk-Based Monitoring (RBM)
Mary Cusack, Associate Director, Bristol-Myers Squibb
Ed Kellar, Director, Global Data Management Operational Support, Astellas, Inc.

Establishing a Quality Management System (QMS)
David Nickerson, Senior Director, Portfolio & Vendor Quality, Pfizer

Co-Presentation: A Practical Approach to Integrating Technology in the Design and Implementation of a Risk-Based Quality Management Program
Brian Nugent, Associate Director, PALM, Clinical Operations, Gilead Sciences
Angie Maurer, RN, BSN, MBA, Clinical Operations Consultant, PALM/Clinical Operations, Gilead Sciences

Optimizing Risk and Quality in Managing Observational Research
Hady Khoury, Vice President, Global Head, Research & Alliance Services, Peri-Approval & Observational Research, Commercialization & Outcome, ICON plc
Sponsored by: ICON plc

Co-Presentation: ICH E.6 Addendum & Change Management towards a Metrics-Based Future
Andy Lawton, Global Head, Data Management, Biometrics & Data Management, Boehringer Ingelheim Ltd.
Jean Baumann, Change Management Specialist, JMB Consulting, LLC

Presentation to be Announced
Speaker to be Announced, Remarque Systems, Inc.

Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com.

For details on sponsorship, exhibit and lead generation packages, contact Ilana Quigley, Tel: 781-972-5457, iquigley@healthtech.com.

For more information, visit http://www.clinicaltrialsummit.com/clinical-trial-monitoring.

About Clinical Trial Oversight Summit

Cambridge Healthtech Institute's Fifth Annual Clinical Trial Innovation Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2016 program focuses on key issues and opportunities in the clinical trial industry, including patient recruitment, site selection, data integration, mobile technologies, project management, outsourcing, budgeting, quality in trial conduct, risk-based monitoring and auditing.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation Bio-IT World Clinical Informatics News and Diagnostics World.

Contact
James Prudhomme
Cambridge Healthtech Institute
jprudhomme@healthtech.com
7819725400
End
Source: » Follow
Email:***@healthtech.com Email Verified
Tags:Clinical, Risk-Based Monitoring, Clinical Trial Quality
Industry:Medical
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share